US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
USOTC
Salmar ASA (PK) (SALRY) 銘柄情報

Salmar ASA (PK) (SALRY)

11.68

0.34

(3.00%)

終了 7月4日 5:00AM

Salmar ASA (PK) (SALRY) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

11.68

( 3.00% )

買値

11.49

売値

11.94

出来高

29,470

11.665 日の範囲 11.74

9.834 52 週間の範囲 16.17

時価総額

前日終値

11.34

始値

11.72

時刻

最終取引時間

財務取引量

US$ 344,770

VWAP

11.699

平均取引量 (3 か月)

US$ 201,741

発行済株式数

135,538,162

配当利回り

10 (1.86%)

PER

33.05

1 株当たり利益 (EPS)

15.07

歳入

28.63B

純利益

2.03B

SalMar ASA, an aquaculture company, produces and sells farmed salmon in Norway, Asia, Europe, North America, and internationally. The company operates through Fish Farming Central Norway, Fish Farming Northern Norway, Icelandic Salmon, Sales & Industry, and SalMar Aker Ocean segments. It also engage... SalMar ASA, an aquaculture company, produces and sells farmed salmon in Norway, Asia, Europe, North America, and internationally. The company operates through Fish Farming Central Norway, Fish Farming Northern Norway, Icelandic Salmon, Sales & Industry, and SalMar Aker Ocean segments. It also engages in the broodstock, marine-phase farming, harvesting, processing, and smolt production activities. In addition, the company offers fish fillets and related products. SalMar ASA was incorporated in 1991 and is headquartered in Kverva, Norway. 詳細を表示

セクター

Consumer Staples

業界

Consumer Products - Foods

ウェブサイト

www.salmar.no

本社

Kverva, Norway

設立

1991

Salmar ASA (PK) is listed in the Consumer Staples sector of the その他OTC with ticker SALRY. The last closing price for Salmar ASA (PK) was US$11.34. Over the last year, Salmar ASA (PK) shares have traded in a share price range of US$ 9.834 to US$ 16.17.

Salmar ASA (PK) currently has 135,538,162 shares in issue. The market capitalisation of Salmar ASA (PK) is US$1.58 billion. Salmar ASA (PK) has a price to earnings ratio (PE ratio) of 33.05.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.77	-13.1598513011	13.45	13.48	11.29	28706	12.19012216	CS
4	-3.064	-20.7813347802	14.744	14.79	11.29	21833	13.32547085	CS
12	-3.49	-23.005932762	15.17	16.17	11.29	14415	14.12406006	CS
26	-3.71	-24.1065627031	15.39	16.17	11.29	14877	14.38547969	CS
52	1.16	11.0266159696	10.52	16.17	9.834	17027	12.90633721	CS
156	1.65	16.4506480558	10.03	17.2	9.834	10566	12.52186399	CS
260	-5.22	-30.8875739645	16.9	21.68	7.27	10696	12.70051757	CS

SALRY - Frequently Asked Questions (FAQ)

What is the current Salmar ASA (PK) share price?

The current share price of Salmar ASA (PK) is US$ 11.68

How many Salmar ASA (PK) shares are in issue?

Salmar ASA (PK) has 135,538,162 shares in issue

What is the market cap of Salmar ASA (PK)?

The market capitalisation of Salmar ASA (PK) is USD 1.58B

What is the 1 year trading range for Salmar ASA (PK) share price?

Salmar ASA (PK) has traded in the range of US$ 9.834 to US$ 16.17 during the past year

What is the PE ratio of Salmar ASA (PK)?

The price to earnings ratio of Salmar ASA (PK) is 33.05

What is the cash to sales ratio of Salmar ASA (PK)?

The cash to sales ratio of Salmar ASA (PK) is 2.35

What is the registered address of Salmar ASA (PK)?

The registered address for Salmar ASA (PK) is Industriveien 51, Kverva, Sør-Trøndelag, 7266

What is the Salmar ASA (PK) website address?

The website address for Salmar ASA (PK) is www.salmar.no

Which industry sector does Salmar ASA (PK) operate in?

Salmar ASA (PK) operates in the Consumer Products - Foods sector

j e d

This is the biggest thing since the Advent acquisition, if not bigger.

JAB65

Never thought about that. That would certainly save them a few hundred million. Is there enough capacity, compression or whatever the criteria is to piggyback on Williams? Would they prefer to have their own control with a new station?

fredscott36

fredscott36 2分前

..dude......will get 'em both, and the G-wagon is ordered, and the 4-runner......not firm on the wrangler, but definitely a wrangler............gotta fill up the garages with a new fleet.........boys toys................($40mios in the tip jar??)...............

.....the POS.....???.

US Market News

US Market News 3分前

Robert Half receives three Canadian HR Reporter Readers' Choice Awards 2026, for 11th consecutive yearJuly 3, 2026 12:38 PM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"July 3, 2026 /CNW/ - Global talent so

KeepItRealistic

KeepItRealistic 3分前

$OSRH to new long investors buy 10k shares and HOLD and while turning your 10k shares to 60k shares 👇

• Details: One non-transferable CVR per share held as of the record date (targeted for July 31, 2026). Subject to legal counsel approval.

• Tiered Rewards: T

williamssc

williamssc 6分前

Slide16 “Overall Conclusions: The survival benefit associated with DCVax-L treatment reflects a true treatment affect and was underestimated in the original analysis”

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

NASDAQ2020

NASDAQ2020 7分前

i will wait for Monday to grab some more ??

GoodGuyBill

GoodGuyBill 8分前

Brazen22, you’re trying to reduce three years of regulatory progress to one sentence: “You don’t have an approved MAA.”

Of course we don’t — yet. Approval is the destination. We have a validated MAA. What matters is whether NWBO has completed the steps that regulators require before a

NASDAQ2020

NASDAQ2020 8分前

THATS WHEN i ACCUMULATE. At The hammerbottom.

nowwhat2

nowwhat2 8分前

Nonbelievers . . . . . C L E A R The R U N W A Y
$3.50 CDN is pretty strong support.

https://investorshub.advfn.com/uimage/uploads/2026/7/3/vwgethg_july_3_2y_plunge_sell.jpg

rizona

rizona 10分前

Slides! JAMA study UNDERESTIMATED survival benefit

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

rosemountbomber

rosemountbomber 11分前

I agree with your thinking and also what needs to be considered is after decimating the board, just a desire to be acquired doesn’t automatically make that happen. Some other party has to be interested in acquiring Amarin. What happens then if no one steps up?

chereb19

chereb19 12分前

This is another post built on false equivalence. Sharing Y-90 doesn't make two products the same any more than sharing aspirin makes every painkiller identical.

You keep calling them competitors while ignoring they're fundamentally different technologies. One is a hydrogel platform, t

NASDAQ2020

NASDAQ2020 13分前

Im glad I held my shares past $0.15

Idunno

Idunno 13分前

And don’t forget your buddy, AF. … .. .

Doc logic

Doc logic 13分前

HappyLibrarian,

You are mistakenly overstating my claim which is a common problem so no harm no foul. Manufacturing transition preparedness is what I am suggesting must be in place. Artisan will be utilized to start as NWBO has consistently stated and the MIA is based on that model.

rcaselli

rcaselli 14分前

Just knowing JCTB1 is here is good enuf for me, okay.
See ya all topside….
$LBRG

Idunno

Idunno 14分前

Have at it Brazen! ;) … .. . :)

CatfishHunter

CatfishHunter 16分前

Every biotech founder believes their design choice was the right one — that’s true of BetaGlue’s surgeon-founder and it was true of Fisher/Korenko too. Design rationale explains intent, not outcome. The question that matters is what the trial data shows for each product, not why either team picked t

asp42001

asp42001 16分前

Digital USIO & AI Payment Potential:

(USIO In-Part):

"Embedded payments are the hidden engine under the hood of the apps and platforms we use every day. When you buy a ticket through a sports app or pay for a round of golf lessons online, embedded payments are doing the

BigBadWolf

BigBadWolf 17分前

$Ownership😘 of @ this point w/ irrefutable DD
🤔https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177573771&txt2find=reactor

mgland

mgland 18分前

https://x.com/thommic/status/2072760144774005081

GTF

Just so you know the clock on the 12 month restricted period for SNTX divvy shares began on June 17th, 2026. It doesn't matter that the deliverance of shares to the gtvh shareholders is taking some time. The clock begins when SNTX creates and issues the shares...meaning the day OTCmarkets shows the

manibiotech

manibiotech 20分前

I like this line in couple of PSM analysis slides:

“ Conclusion: Based on these more precisely matched comparisons,
the survival benefit with DCVax-L was likely underestimated
in the original analysis”

Very encouraging . Now let’s see when MHRA does its jo

Salmar ASA (PK)

AB Active ETFs I

L&G Metaverse UCITS ETF

King Resources (QB)

RSE Archive (GM)

Obsidian Energy

Regions Financial

Amundi MSCI Emg Mrkts SR...

Red Mountain Mining

Anfield Enhanced Market ...

Valeo Pharma (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。